Immunome
-
Frontage Laboratories Expands to 200,000 SF of Life Science Space at Hankin Group’s Eagleview in Exton
Frontage Laboratories, a full-spectrum Contract Development and Manufacturing Organization (CDMO), now occupies an additional 46,300 square feet of life sciences space at Hankin Group’s Eagleview…
-
Exton’s Immunome Moves HQ to Seattle Following Merger
Exton-based biopharmaceutical company Immunome has completed a reverse merger with a Seattle-based company dedicated to making strides in cancer therapies, writes John George for the…
-
Exton-Based Immunome’s Antibody Cocktail May Be Omicron’s Kryptonite
Exton-based Immunome has reported positive results from testing its antibody cocktail against live versions of the omicron variant of COVID-19. John George broke through the…
-
Neither the Pandemic Nor Labor Shortages Could Mute Phila.’s 2021 Venture Capital Boom
Despite the disruptions caused by the coronavirus pandemic and labor shortages, Philadelphia experienced a venture capital boom in 2021, write Taylor Allen and Mike D’Onofrio…
-
With Omicron Variant Now in the U.S., Could Exton-Based Immunome’s ‘Antibody Cocktail’ Be the Neutralizer?
Exton-based Immunome has submitted an application with the FDA to start human testing its “antibody cocktail” as a potential COVID-19 treatment, writes John George for…
-
Exton-Based Biopharma Firm Has ‘Potential to Prepare Country in Event of Another Big Wave of COVID-19’
Exton-based Immunome is developing an “antibody cocktail” to fight COVID-19 variants of concern. The World Health Organization and Center for Disease Control classified these mutations…
-
Biotech Company in Exton Aims to Raise $27 Million to Further Its Potential COVID-19 Therapy
Exton-based Immunome has entered into a deal with a group of accredited investors to raise $27 million through a private stock placement, writes John George…
-
Exton-Based Biotech Company’s Stock Balloons After Discovering Antibodies That Neutralize COVID-19 Variants
Immunome saw its stock soar after the Exton-based company discovered antibodies that have shown, in early testing, the ability to neutralize multiple variants of COVID-19,…
-
Local Office Markets Thriving as Some Philadelphia Startups Head to Suburbs During Pandemic
Local commercial real estate markets are thriving as a number of Philadelphia startups search out more affordable space in the suburbs due to the coronavirus…
-
Exton-Based Biopharmaceutical Company Enjoys Prosperous Stock Market Debut
Immunome, an Exton-based biopharmaceutical company, went public last week and managed to raise $39 million through an upsized initial public stock offering, writes John George…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
